Search research articles
Contact Us
Filters
Showing results (131-140 of 195) with videos related to
Page
of 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entity
Andrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
Giovanna Rossi, Zhaomei Mu, Alfred W Rademaker, et al.
Breast Cancer Research and Treatment
|
August 12, 2003
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003
Harry Bartelink, Christopher Benz, Don Cleveland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2020
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE
Stephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 2, 2006
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
Robert W Carlson, Elizabeth Brown, Harold J Burstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2017
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE
Stephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
Martee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Oncotarget
|
May 4, 2018
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Cesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, et al.
The Journal of Clinical Investigation
|
November 18, 2025
USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I
Kun Liu, Radhika Iyer, Yi Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2019
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Amelia McCartney, Chiara Biagioni, Gaia Schiavon, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 195) with videos related to
Sort By:
Page
of 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entity
Andrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
Giovanna Rossi, Zhaomei Mu, Alfred W Rademaker, et al.
Breast Cancer Research and Treatment
|
August 12, 2003
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003
Harry Bartelink, Christopher Benz, Don Cleveland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2020
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE
Stephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 2, 2006
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
Robert W Carlson, Elizabeth Brown, Harold J Burstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2017
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE
Stephen R D Johnston, Roberto Hegg, Seock-Ah Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants
Martee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Oncotarget
|
May 4, 2018
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer
Cesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, et al.
The Journal of Clinical Investigation
|
November 18, 2025
USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I
Kun Liu, Radhika Iyer, Yi Li, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2019
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Amelia McCartney, Chiara Biagioni, Gaia Schiavon, et al.
Page
of 20